Dunamu, through its investment subsidiary Dunamu & Partners, has made an additional investment in the medical big data company Inocras, bringing the total investment amount to 14.5 billion KRW. Since its initial investment in 2022, Dunamu & Partners has participated in four rounds of financing for Inocras. In the latest financing round, Inocras raised a total of 31 million USD (approximately 45.1 billion KRW), with new investors including IMM Investment, Korea Investment & Securities, Woori Investment & Securities, and Shinhan Investment & Securities, while previous investors DSC Investment and InterVest also continued to participate.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.





























